COVID-19 monoclonal antibodies reduce risk of hospitalization and death
Better donor evaluation, drug therapy in sight for kidney transplants
18 May 2021Elevated pulse rate in non-sleepy OSA heart patients may lead to serious cardiac events
18 May 2021COVID-19 monoclonal antibodies reduce risk of hospitalization and death
Monoclonal antibodies, a COVID-19 treatment given early after coronavirus infection, cut the risk of hospitalization and death by 60% in those most likely to suffer complications of the disease, according to an analysis of UPMC patients who received the medication compared to similar patients who did not.
